🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "focused steps to address household expense pressures" in the forthcoming Budget.

In comments to the BBC, she noted that lowering price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Cost Measures

Reports indicate the government could intervene to bring down utility costs, for instance by cutting the current 5% rate of value-added tax applied on energy supplies.

Another option is to lower some of the policy costs currently included in household expenses.

Fiscal Constraints and Analyst Expectations

The administration will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will show how much space there is for such measures.

The view from most analysts is that the Chancellor will have to announce tax increases or expenditure reductions in order to fulfill her declared fiscal targets.

Previously on Thursday, calculations indicated there was a twenty-two billion pound gap for the chancellor to address, which is at the lower end of forecasts.

"It is a joint job between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves stated to reporters in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Concerns

While much of the attention has been on probable tax rises, the Treasury chief said the latest information from the fiscal watchdog had not altered her pledge to manifesto promises not to raise tax levels on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with rising geopolitical and trade concerns for the fiscal revenue measures, likely to be directed on those "most able to pay."

International Economic Disputes

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests always come first."

Recent declaration by China to increase trade restrictions on critical minerals and other resources that are key for high-technology production led US President the US President to threaten an additional 100% tariff on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two economic giants.

The American finance chief called the Chinese decision "economic coercion" and "a global supply chain control attempt."

Asked about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and creates further challenges."

"I believe there are sectors where we need to confront China, but there are also valuable chances to trade with China's economy, including financial services and other sectors of the economy. We've got to achieve that equilibrium correct."

The chancellor also stated she was working with international partners "on our own essential resources plan, so that we are less reliant."

NHS Drug Pricing and Investment

Reeves also admitted that the price the National Health Service pays for pharmaceuticals could increase as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the biggest global drug companies have said recently that they are either pausing or abandoning investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the price the NHS pays for medicines would must increase to prevent firms and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen due to the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the UK in the way that they are in other European countries."

"Our aim is to ensure that individuals receiving treatment from the NHS are able to obtain the best life-saving medicines in the globe. And so we are looking at all of that, and... aiming to attract more capital into Britain."